Inositol for PCOS — Myo vs D-Chiro, the 40:1 Ratio, Dosing & What the Evidence Actually Shows
- Inositol has the strongest evidence base of any supplement specifically studied for PCOS — and is the only supplement recommended in the 2023 International PCOS Guideline.
- Myo-inositol (MYO) and D-chiro-inositol (DCI) are two different forms that work through different mechanisms — myo-inositol primarily improves insulin signalling and egg quality, DCI primarily stimulates glycogen synthesis.
- The 40:1 MYO:DCI ratio mirrors the physiological ratio found in human tissues and has the strongest evidence for restoring ovulation and hormonal balance in PCOS.
- The standard evidence-based dose is 4,000 mg of myo-inositol per day (or 4,000 mg MYO + 100 mg DCI in the 40:1 combination) — taken in two divided doses.
- Results typically appear within 3–6 months — improved cycle regularity, reduced testosterone, and improved insulin sensitivity are the most consistently reported outcomes.
- Inositol is generally well tolerated with minimal side effects — GI discomfort at high doses is the most common complaint and resolves by reducing dose temporarily.
- The 2023 PCOS Guideline notes the evidence is promising but acknowledges it remains limited and inconclusive in some areas — use it as a complement to lifestyle intervention, not a replacement.
Walk into any PCOS community online and inositol comes up constantly — and for good reason. It's the supplement with more clinical trial data specifically in PCOS than any other, it has a mechanistically coherent explanation for why it works, and it has a genuinely good safety profile. But the information about it is also frequently oversimplified, incorrectly dosed, or confused between the two forms.
This article covers the actual science — what myo-inositol and D-chiro-inositol are, why the ratio matters, what the evidence shows for each outcome, and how to use it correctly. Including the honest caveat that the 2023 International PCOS Guideline calls the evidence "limited and inconclusive" in some areas — which doesn't mean it doesn't work, but does mean it's not a magic pill.
What inositol is — and why PCOS disrupts it
Inositol is a naturally occurring carbohydrate compound — often called a "pseudo-vitamin" — that functions as a second messenger in multiple hormonal signalling pathways. It is produced by the body and found in small amounts in food (especially citrus fruits, beans, grains, and nuts), but dietary intake is far too low for therapeutic effect — supplementation is the only route to the doses used in clinical trials.
Two forms are relevant for PCOS:
- Second messenger for FSH (follicle-stimulating hormone) in the ovaries
- Improves insulin receptor signalling in cells
- Supports egg maturation and quality
- Found in high concentration in follicular fluid
- The form most studied and with strongest evidence in PCOS
- Second messenger for insulin action in peripheral tissues
- Stimulates glycogen synthesis — glucose storage in muscle and liver
- Reduces androgen production in the ovaries
- Should NOT be used in high concentrations in the ovaries
- DCI alone may worsen egg quality at high ovarian concentrations
Here's the critical PCOS-specific finding that explains why the ratio between these two forms matters so much: in women without PCOS, the ovarian MYO:DCI ratio is 100:1. In women with PCOS, that ratio is 0.2:1 — an almost complete inversion. The ovaries of people with PCOS have far too little myo-inositol relative to D-chiro-inositol, which impairs FSH signalling, egg development, and ovulation.
This matters because excessive DCI supplementation — particularly in the absence of adequate MYO — can further suppress ovarian myo-inositol and worsen egg quality. It's the reason DCI alone is not recommended, and why the ratio of the combination matters more than the total dose.
The 40:1 ratio — why it matters
The 40:1 MYO:DCI ratio emerged from research into the physiological ratio found in human plasma, which approximates 40:1. Supplementing in this ratio was hypothesised to restore the tissue-level balance disrupted by PCOS's insulin-driven conversion of MYO to DCI.
A prospective controlled randomised trial comparing seven different MYO:DCI ratios in 56 PCOS patients found that the 40:1 ratio was the most effective for restoring ovulation — outperforming DCI alone, and ratios both below and above 40:1 on ovulation restoration. A 2024 narrative review confirmed that MYO alone shows positive results, but the MYO:DCI combination is most effective when used at a ratio of at least 40:1.
What the evidence shows — by outcome
| Outcome | Evidence quality | What the research shows |
|---|---|---|
| Insulin sensitivity / HOMA-IR | Strong | Multiple RCTs show significant HOMA-IR reduction with myo-inositol supplementation. Effect comparable to Metformin in some comparisons, with fewer GI side effects. |
| Testosterone reduction | Strong | Consistent reduction in total and free testosterone across trials. Mechanism: improved insulin sensitivity reduces the insulin-driven ovarian androgen production. |
| Ovulation restoration | Strong | The 40:1 MYO:DCI ratio specifically restores ovulation more effectively than other ratios. Multiple studies show improved ovulation rates and more regular cycles. |
| Menstrual cycle regularity | Strong | Consistently improved across trials — typically appearing by month 3 of supplementation. One of the most reliably reported patient-experienced benefits. |
| Egg quality (ART outcomes) | Moderate | A 2025 systematic review and meta-analysis found meaningful evidence for myo-inositol and DCI on ART outcomes in PCOS undergoing IVF — improved fertilisation rates and embryo quality reported across multiple trials. |
| LH and FSH normalisation | Moderate | Improved LH:FSH ratio reported in several trials — consistent with reduced hyperinsulinemia-driven LH excess. |
| Weight loss | Limited | The 2023 PCOS Guideline meta-analysis found Metformin may improve waist-hip ratio and hirsutism compared to inositol, with likely no difference for reproductive outcomes. Inositol is not primarily a weight loss supplement — expect modest effects on weight at best. |
| Acne and hirsutism | Limited / indirect | Improvements reported in some studies, likely mediated through testosterone reduction rather than direct effect. Effect is slower and less pronounced than hormonal contraception. |
Evidence-based dosing
| Form | Recommended dose | Timing | Notes |
|---|---|---|---|
| Myo-inositol alone | 2,000–4,000 mg/day | Split into 2 doses, ideally before meals | The most studied approach. 4,000 mg/day is used in the majority of clinical trials. Start at 2,000 mg and increase after 2 weeks if well tolerated. |
| 40:1 MYO:DCI combination | 4,000 mg MYO + 100 mg DCI per day | Split into 2 doses of 2,000 mg MYO + 50 mg DCI | The ratio with the most clinical trial support for ovulation restoration. Look for products that explicitly state the 40:1 ratio — many combination products use different ratios. |
| DCI alone | Not recommended | — | Insufficient or controversial evidence. High DCI without adequate MYO may worsen ovarian function by further depleting follicular MYO. Avoid. |
| Inositol + Metformin | Standard inositol dose alongside prescribed Metformin dose | As above for inositol; Metformin with food | A Phase III RCT found that fixed-dose Metformin plus myo-inositol produced enhanced metabolic and reproductive outcomes compared to Metformin alone — a synergistic combination since the two agents work through different mechanisms. Discuss with your prescriber before combining. |
Not all inositol supplements are created equal. The ratio matters — look for products that clearly state a 40:1 MYO:DCI ratio on the label. Products with a 3.6:1 or other ratios exist (an ongoing 2025 clinical trial is comparing 40:1 vs 3.6:1 directly) but have less established evidence for PCOS outcomes. Powder form is generally better absorbed than capsules at the doses required. Third-party tested products reduce risk of contamination and inaccurate dosing.
How inositol compares to Metformin
This is the question most people with PCOS on or considering Metformin want answered. The honest comparison:
- For insulin sensitivity: Comparable effects in several trials — inositol and Metformin produce similar HOMA-IR improvements in head-to-head comparisons
- For reproductive outcomes: The 2023 PCOS Guideline meta-analysis found likely no difference between inositol and Metformin for reproductive outcomes — meaning they're similarly effective for ovulation and cycle regularity
- For side effects: Myo-inositol likely causes fewer GI adverse events than Metformin — though Metformin's GI effects are typically mild and self-limited
- For waist-hip ratio and hirsutism: Metformin appears to have an edge in these specific outcomes
- For availability: Metformin requires a prescription; inositol is available over the counter
- For combining: The two work through different mechanisms and have synergistic effects when combined — you don't have to choose one or the other
For people who cannot tolerate Metformin's GI side effects, inositol is a well-supported alternative with comparable reproductive outcomes. For people who can tolerate Metformin, adding inositol to their regimen produces additional benefit beyond either alone. For people not yet on Metformin who are considering supplements only, inositol is the most evidence-based first choice — but should complement, not replace, the dietary and lifestyle interventions that address insulin resistance at the source.
Timeline — what to expect and when
- Weeks 1–4: Improved energy and reduced sugar cravings are often reported early — these reflect early improvements in insulin signalling before hormonal markers change measurably
- Month 2–3: First improvements in cycle regularity typically appear. Some women report their first regular cycle within 2–3 months of consistent supplementation
- Month 3–6: Measurable reductions in testosterone and LH, improved HOMA-IR, and more consistent ovulatory cycles in most clinical trials
- Month 6+: Where fertility-related outcomes (improved ART results, higher spontaneous pregnancy rates) become most significant in the trial data
Give inositol at least 3 months at the full dose before evaluating whether it's working. Hormonal and metabolic changes take time to manifest — and the ovarian environment that inositol is restoring (follicular fluid MYO concentration) takes weeks to months to change measurably.
Side effects and safety
Inositol has an excellent safety profile across published trials. It is a naturally occurring compound produced by the human body, and supplementation at clinical doses (up to 4,000 mg/day) has not been associated with serious adverse effects in any published trial.
- GI discomfort (nausea, loose stools): The most common complaint, occurring at higher doses. Starting at 2,000 mg/day and increasing to 4,000 mg after 2 weeks typically prevents this. Taking with food also helps.
- No known drug interactions: At standard doses, no clinically significant interactions have been reported — but always inform your prescriber of any supplements you're taking
- Safety in pregnancy: Inositol has been studied in pregnancy (particularly for gestational diabetes prevention) with a good safety profile — but use during pregnancy should be discussed with your OB-GYN
- Bipolar disorder caution: High-dose inositol has been investigated for mood disorders and may affect mood stability in susceptible individuals — if you have a bipolar diagnosis, discuss with your psychiatrist before starting
Frequently asked questions
Can I take inositol without a prescription?
Yes — inositol is available over the counter as a dietary supplement in most countries. It does not require a prescription. However, if you are being treated for PCOS with Metformin or other medications, inform your prescriber that you are adding inositol — the two work synergistically and your prescriber should know your full supplement regimen.
Is the 40:1 ratio supplement the same as taking myo-inositol alone?
Not exactly — the 40:1 combination provides DCI alongside MYO for peripheral insulin signalling, while MYO alone addresses ovarian function and FSH signalling without the DCI component. The clinical evidence slightly favours the 40:1 combination for ovulation restoration specifically. For general insulin sensitivity and metabolic outcomes, MYO alone has the most robust evidence base.
Should I take inositol if I am trying to conceive?
A 2025 systematic review found meaningful evidence for myo-inositol and DCI on ART outcomes in PCOS — including improved fertilisation rates and embryo quality. Inositol is commonly used during IVF preparation for PCOS patients. Discuss timing and dosing with your reproductive endocrinologist, particularly around the egg retrieval cycle.
How long do I need to take inositol?
Most clinical trials run for 3–6 months. For cycle regulation and fertility, a 6-month course is a reasonable initial commitment. Some people with PCOS take inositol long-term as part of ongoing metabolic management — the safety profile supports this, but it's worth periodically reassessing with your doctor whether continued supplementation is producing ongoing benefit.
Does inositol work for lean PCOS?
Yes — inositol's mechanism (improving insulin signalling and restoring ovarian MYO:DCI ratio) is relevant regardless of body weight, since insulin resistance in PCOS occurs in lean women too. Several trials specifically include lean PCOS patients and show comparable outcomes to overweight groups for hormonal and reproductive endpoints.
What does the 2023 International PCOS Guideline actually recommend?
The 2023 PCOS Guideline states that the evidence supporting the use of inositol in PCOS management is limited and inconclusive, and that clinicians and patients should consider the uncertainty of the evidence together with individual values and preferences when making decisions. This is a cautious but not dismissive position — it acknowledges benefit signals while noting that the evidence base is not yet as robust as for Metformin. Inositol is the only supplement mentioned in the Guideline at all, which reflects its status as the best-evidenced option in the category.
Inositol works by improving insulin signalling — knowing your HOMA-IR score helps set realistic expectations for how much improvement to expect and how to combine it with dietary changes.